Skip to content
Review

Multimodal approaches in precision psychiatry.

Aug 2026 · International Review of Psychiatry · pp. 1-10 · 0 citations · 72 references
Medicine

TL;DR

This review presents a conceptual framework for precision psychiatry that emphasizes multimodal approaches, and describes key sources of information, including demographic and psychosocial factors, as well as biological data, particularly neuroimaging, genetics, and molecular profiling.

Abstract

Precision psychiatry is an emerging framework that seeks to improve diagnosis, prognosis, and treatment in mental disorders through the integration of biological, behavioral, environmental, and clinical information. Current diagnostic systems show substantial heterogeneity within categories and symptom overlap across disorders, reflecting limited biological validity and constraining treatment development. This review presents a conceptual framework for precision psychiatry that emphasizes multimodal approaches. We describe key sources of information, including demographic and psychosocial factors, as well as biological data, particularly neuroimaging, genetics, and molecular profiling. We also outline analytic strategies designed to move beyond showing average associations, including mediation and interaction analyses and machine learning approaches that enable the evaluation of intermediate pathways and heterogeneous effects. Despite increasing availability of multimodal data, key challenges include limited clinical utility of biomarkers when used in isolation and insufficient availability of integrated datasets. Shared infrastructures and validated analytic platforms are essential to support multimodal approaches and translation into clinical care.

View source

Similar papers

Review Aug 2026

Towards precision psychiatry: initial foundations and future directions.

This Perspective discusses mechanistic approaches that focus on excitation-inhibition balance, reward and aversion circuits, hippocampal-prefrontal neuroplasticity, and processing of social cues, highlighting how these frameworks can elucidate drug mechanisms and predict treatment responses.

Amit Etkin, P. O’Donnell, K. Ressler et al. · 0 citations
Open access Sep 2026

537. Bridging the translational gap in psychiatry using a multimodal multi-omics collaboration: the consortium for preclinical psychiatric research

Abstract Background There is a critical need to change the treatment paradigm for mental disorders by developing interventions that are able to target specific clinical components, alter the disease course and are not merely palliative in intent. A key strategy towards this goal is to focus research on causal pathways...

S. Sundram · 0 citations
Review Open access Aug 2026

Precision psychiatry in clinical practice: What is clinically actionable, what is promising, and what remains experimental?

Precision psychiatry seeks to improve individual-level prediction, treatment selection, monitoring, and prevention by integrating clinical, biological, behavioural, digital, and contextual information. This structured narrative review assessed the clinical readiness of major approaches using a purpose-specific framewor...

J. Torales, M. O'Higgins, Iván Barrios et al. · 0 citations
Review Open access Sep 2026

863. Mapping the global biomarker landscape in anxiety, depression and psychosis: a global infrastructure and consensus initiative for precision psychiatry

Abstract Background Biomarker research in psychiatry has expanded rapidly across genetic, molecular, neuroimaging, electrophysiological, behavioural and digital domains. Despite substantial scientific progress, few biomarkers have achieved routine clinical implementation. Translation is hindered by fragmented evidence,...

D. Bocancea, L. Zhou, M. Kas · 0 citations
Review Open access Sep 2026

Neurobiological mechanisms and brain network dysfunction in major depressive disorder: an integrative review

Major depressive disorder (MDD) is a prevalent and disabling psychiatric disorder characterized by persistent mood disturbances, cognitive impairments, and significant systemic consequences. Despite its substantial clinical burden, diagnosis remains challenging because current approaches rely largely on subjective symp...

D. Iskakova, Burcu Yener, A. Kamzanova et al. · 0 citations
Review Open access Aug 2026

Mapping the Heterogeneity of Major Depressive Disorder: A Systematic Review of Multi-Omics Integration Studies

Results indicate that multi-omics integration, in addition to explaining the molecular architecture of MDD, also characterizes patient subgroups with pathophysiological mechanisms, dimensions of symptoms, and disease treatment, which demonstrates that there is a shift in psychiatry toward a more mechanistic approach.

Elham Amjad, B. Sokouti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.